United Therapeutics Corporation (UTHR) has 14 known insider and institutional holders on record. The largest holder is EDGEMOND JAMES with 18,876 shares. Other notable holders include MAHON PAUL A and Olian Judy D..
Over the last 12 months, insiders have made 21 transactions in UTHR stock — 0 buys (valued at RSU Award) and 9 sells (valued at $2.32M). Insider selling has exceeded buying during this period.
UTHR Insider Ownership
Top Holder
EDGEMOND JAMES
18,876 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
9
$2.32M value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Edgemond James |
CFO and Treasurer |
18,876 |
2026-04-07 |
|
| 2 |
Mahon Paul A |
EVP & General Counsel |
16,900 |
2026-04-02 |
|
| 3 |
Olian Judy D. |
Director |
5,655 |
2024-11-12 |
|
| 4 |
Giltner Richard |
Director |
5,000 |
2024-11-06 |
|
| 5 |
Mesa Nilda |
Director |
4,883 |
2025-06-25 |
|
| 6 |
Causey Christopher |
Director |
3,675 |
2024-11-04 |
|
| 7 |
Sullivan Louis W |
Director |
3,200 |
2024-12-19 |
|
| 8 |
Maxwell Linda |
Director |
2,890 |
2024-07-26 |
|
| 9 |
Thompson Tommy G |
Director |
2,500 |
2025-03-25 |
|
| 10 |
Rothblatt Martine A |
Chairperson & CEO |
2,500 |
2026-04-07 |
|
| 11 |
Dwek Raymond |
Director |
1,750 |
2025-04-15 |
|
| 12 |
Patusky Christopher |
Director |
900 |
2025-01-13 |
|
| 13 |
Kurzweil Ray |
Director |
590 |
2024-07-26 |
|
| 14 |
Malcolm Jan |
Director |
590 |
2024-07-26 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-04-06 |
Edgemond James |
CFO and Treasurer |
Informative Sell |
200 |
$566.01 |
$113.2K |
| 2026-04-06 |
Rothblatt Martine A |
Chairperson & CEO |
Option Exercise (Sell) |
9,500 |
$146.03 |
$1.39M |
| 2026-04-02 |
Edgemond James |
CFO and Treasurer |
Informative Sell |
120 |
$571.65 |
$68.6K |
| 2026-04-02 |
Rothblatt Martine A |
Chairperson & CEO |
Option Exercise (Sell) |
9,500 |
$146.03 |
$1.39M |
| 2026-04-02 |
Mahon Paul A |
EVP & General Counsel |
Option Exercise (Sell) |
8,300 |
$146.03 |
$1.21M |
| 2026-04-01 |
Rothblatt Martine A |
Chairperson & CEO |
Gift (Given) |
500,000 |
$117.76 |
$58.88M |
| 2026-03-31 |
Rothblatt Martine A |
Chairperson & CEO |
Option Exercise (Sell) |
9,500 |
$146.03 |
$1.39M |
| 2026-03-30 |
Rothblatt Martine A |
Chairperson & CEO |
Informative Sell |
80 |
$581.74 |
$46.54K |
| 2025-06-26 |
Mahon Paul A |
EVP & General Counsel |
Informative Sell |
100 |
$288.80 |
$28.88K |
| 2025-06-24 |
Mesa Nilda |
Director |
Informative Sell |
645 |
$289.99 |
$187.05K |
| 2025-06-24 |
Giltner Richard |
Director |
Option Exercise (Sell) |
5,000 |
$175.43 |
$877.15K |
| 2025-06-12 |
Mahon Paul A |
EVP & General Counsel |
Informative Sell |
200 |
$282.27 |
$56.45K |
| 2025-06-09 |
Edgemond James |
CFO and Treasurer |
Informative Sell |
300 |
$326.81 |
$98.04K |
| 2025-06-02 |
Edgemond James |
CFO and Treasurer |
Informative Sell |
2,653 |
$326.31 |
$865.69K |
| 2025-05-29 |
Mahon Paul A |
EVP & General Counsel |
Option Exercise (Sell) |
4,000 |
$117.76 |
$471.04K |
| 2025-05-15 |
Mahon Paul A |
EVP & General Counsel |
Option Exercise (Sell) |
11,000 |
$117.76 |
$1.3M |
| 2025-05-09 |
Thompson Tommy G |
Director |
Option Exercise (Sell) |
2,500 |
$175.43 |
$438.58K |
| 2025-05-01 |
Mahon Paul A |
EVP & General Counsel |
Option Exercise (Sell) |
11,000 |
$117.76 |
$1.3M |
| 2025-04-21 |
Dwek Raymond |
Director |
Option Exercise (Sell) |
3,000 |
$175.43 |
$526.29K |
| 2025-04-17 |
Mahon Paul A |
EVP & General Counsel |
Option Exercise (Sell) |
11,000 |
$117.76 |
$1.3M |
| 2025-04-14 |
Dwek Raymond |
Director |
Informative Sell |
3,000 |
$285.16 |
$855.48K |
